n-palmitoylsphingosine and Benign Neoplasms

n-palmitoylsphingosine has been researched along with Benign Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, H; Feng, SS; Gao, J; Guo, S; Jiang, J; Kou, G; Li, B; Li, J; Li, W; Niu, F; Song, H; Su, X; Wang, X; Yang, K; Yin, C1
Chan, M; Fuks, Z; GarcĂ­a-Barros, M; Haimovitz-Friedman, A; Hambardzumyan, D; Kaag, M; Kolesnick, R; Stancevic, B; Truman, JP1

Other Studies

2 other study(ies) available for n-palmitoylsphingosine and Benign Neoplasms

ArticleYear
Co-delivery of doxorubicin and PEGylated C16-ceramide by nanoliposomes for enhanced therapy against multidrug resistance.
    Nanomedicine (London, England), 2015, Volume: 10, Issue:13

    Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Ceramides; Doxorubicin; Drug Combinations; Drug Resistance, Neoplasm; Drug Synergism; Glucosyltransferases; Humans; Liposomes; Mice; Neoplasms; Polyethylene Glycols; Up-Regulation

2015
Endothelial membrane remodeling is obligate for anti-angiogenic radiosensitization during tumor radiosurgery.
    PloS one, 2010, Sep-30, Volume: 5, Issue:9

    Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Apoptosis; Cattle; Cell Line, Tumor; Ceramides; Disease Models, Animal; Endothelium; Female; Humans; Male; Mice; Mice, Knockout; Neoplasms; Radiation-Sensitizing Agents; Radiotherapy Dosage; Sphingomyelin Phosphodiesterase; Vascular Endothelial Growth Factor A

2010